| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.087 | 0.8 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |